News/ News/ R&D MDMA on track for 2023 approval as PTSD therapy, says developer Phil Taylor fda, MAPS, MDMA, psychedelics, PTSD 0 Comment A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp Share X MDMA on track for 2023 approval as PTSD therapy, says developer https://pharmaphorum.com/news/mdma-on-track-for-2023-approval-as-ptsd-therapy-says-developer/
News/ News/ R&D Evidence builds for use of MDMA as PTSD therapy Richard Staines MDMA, mental health, midomafetamine, PTSD 0 Comment MDMA has become notorious as an illegal dance drug – but the evidence supporting its approval as a treatment for post-traumatic Share X Evidence builds for use of MDMA as PTSD therapy https://pharmaphorum.com/news/evidence-builds-for-use-of-mdma-as-ptsd-therapy/
